Which receptors are affected in a buspirone (Buspar) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Receptors Affected in Buspirone (Buspar) Overdose

In buspirone overdose, the primary receptors affected are serotonin 5-HT1A receptors (where buspirone acts as a partial agonist) and dopamine D2 receptors (where it acts as an antagonist), with secondary effects on noradrenergic and other neurotransmitter systems. 1, 2

Primary Receptor Targets

Serotonin 5-HT1A Receptors:

  • Buspirone has high affinity for serotonin 5-HT1A receptors and functions as a partial agonist at these sites 1, 2
  • This is the primary mechanism through which buspirone exerts its pharmacological effects 2, 3
  • In overdose, excessive 5-HT1A receptor stimulation can lead to serotonin syndrome-like symptoms, though buspirone has relatively low toxicity 1, 2

Dopamine D2 Receptors:

  • Buspirone has moderate affinity for brain D2-dopamine receptors, where it acts as an antagonist at presynaptic inhibitory D2 autoreceptors 1, 2
  • This antagonism enhances dopaminergic neuron firing rates 4
  • Overdose may amplify dopaminergic effects, contributing to agitation or movement-related symptoms 2, 4

Secondary Receptor and Neurotransmitter Effects

Serotonin 5-HT2 Receptors:

  • Buspirone has weak affinity for 5-HT2 receptors 2, 3
  • This contributes to its overall serotonergic profile but is not the primary mechanism of action 3

Noradrenergic System:

  • At therapeutic doses, buspirone increases noradrenaline levels through central mechanisms 4
  • In overdose, this can lead to elevated peripheral noradrenaline concentrations and sympathetic activation 4
  • This effect is mediated through sympathetic nerves rather than adrenal glands 4

Other Neurotransmitter Systems:

  • Buspirone may have indirect effects on glutamatergic, cholinergic, and other neurotransmitter systems 1, 5
  • These effects are mediated through the wide distribution of 5-HT1A receptors on various neuronal types 5

Critical Distinctions from Benzodiazepines

GABA Receptors NOT Affected:

  • Buspirone has no significant affinity for benzodiazepine receptors 1, 2
  • It does not affect GABA binding in vitro or in vivo 1
  • Therefore, flumazenil (a benzodiazepine antagonist) has no role in buspirone overdose management 1

Clinical Manifestations of Receptor Effects in Overdose

Serotonergic Effects:

  • Mental status changes (confusion, agitation) from excessive 5-HT1A stimulation 6, 2
  • Potential for serotonin syndrome when combined with other serotonergic agents 6

Cardiovascular Effects:

  • Increased free serotonin can lead to decreased systolic blood pressure and heart rate through parasympathetic activation 4
  • Noradrenergic stimulation may cause elevated blood pressure and tachycardia 4
  • These opposing effects create variable cardiovascular presentations in overdose 4

Neurological Effects:

  • Dizziness, nervousness, and lightheadedness from combined receptor effects 3
  • Minimal sedation compared to benzodiazepines due to lack of GABA effects 1, 3

Key Clinical Pitfall

Do not treat buspirone overdose with flumazenil – buspirone does not bind to benzodiazepine receptors, so benzodiazepine antagonists are ineffective and inappropriate 1, 2. Management should focus on supportive care addressing serotonergic and dopaminergic effects rather than GABA-mediated toxicity.

References

Research

Buspirone: what is it all about?

Brain research, 2012

Research

Effects of buspirone on plasma neurotransmitters in healthy subjects.

Journal of neural transmission (Vienna, Austria : 1996), 1998

Research

[Antidepressants, stressors and the serotonin 1A receptor].

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2015

Guideline

Safety Monitoring and Contraindications for Combined Buspirone + Adderall XR Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.